Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ciclosporin in HAM/TSP
NCT00773292Phase 3Completed
- Sponsor
- Imperial College London
- Start
- Aug 2006
- Primary completion
- Jan 2010
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of cyclosporine in HTLV-I associated myelopathy (HAM/TSP), sponsored by Imperial College London. Started Aug 2006; status: completed.
02
Drugs
cyclosporine
03
Conditions
HTLV-I associated myelopathy (HAM/TSP)
Beyond the preview
Go deeper on NCT00773292.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00773292.